PUBLICATIONS
OPRI has been leading the paradigm shift in real world evidence for the past 12 years, by delivering pragmatic clinical trials, disease registries and database research.
OPRI’s founder, Professor David Price, has been a pioneer in setting new quality standards for database research which are fully adhered to by the research institute.

2020 Publications COPD
Advancing the Patient Experience (APEX) in COPD registry: Study design and strengths - Accpeted in Journal of the American Board of Family Medicine
Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPD - Accepted in ERJ Open Research
Development of the Advancing the Patient EXperience (APEX) in COPD registry: a modified Delphi Study - Accepted in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
2020 Publications | Severe Asthma
Potential severe asthma hidden in UK primary care - JACI In Pract (Severe Asthma)
Evaluating the Real-life Effect of MP-AzeFlu On Asthma Outcomes In Patients With Allergic Rhinitis and Asthma In UK Primary Care - WAO J
2019 Publications
AAAAI 2020 Annual Meeting

REG 2020
Cluster analysis according to biomarker profile differentiates clinical subgroups in the International Severe Asthma Registry (ISAR)
COPD Primary Care: Providing a Clinically Relevant Picture for Clinicians
ATS 2020

Global Access for Biologics in the Treatment of Severe Asthma: A Challenge to Personalized Medicine
Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)
A Global Survey of Blood Eosinophil Distribution in Severe Asthma Patients: Data from the International Severe Asthma Registry (ISAR)
Biomarker Relatability in the International Severe Asthma Registry
Disease Burden for Patients with Chronic Obstructive Pulmonary Disease Receiving Maintenance Therapy